Company KDA Group Inc.

Equities

KDA

CA48669F1071

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 20:47:51 13/05/2024 BST			5-day change	1st Jan Change
0.395 ^CAD	+3.95%		-7.06%	+97.50%

03-28	KDA Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
03-21	KDA Group Inc. Announces an Update in the Development and Use of Its Adherize+ Platform	CI

KDA Group Inc. is a Canada-based solution and services provider to pharmacies and pharmaceutical companies in Canada as well as technological platform for the health industry. The Companyâs segments include Pharmacy Services, Pharmaceutical Solutions and Pharmaceutical Technology. Its Pharmacy Services segment offers training, consulting, and replacement services for professional resources in the field of healthcare. Its Pharmaceutical Solutions segment is engaged in the development and integration of technological platforms dedicated to all healthcare professionals. Its Pharmaceutical technology segment offers KRX, KRX DENTAL and ADRX platforms. It also offers ZRx Digital Prescriber an electronic prescriber computer and mobile software designed and developed for use by healthcare providers who are authorized to prescribe medications and other treatments. Its subsidiaries include Alliance Pharma Operations Inc., Elitis Pharma Inc., Logistik Pharma Inc. and Groupe Technologique KDA Inc.

CAD in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical Technology 59.0 %	0	0.7 %	0	59.0 %	-54.11%
Corporate and Others 41.0 %	0	0.0 %	0	41.0 %	-

CAD in Million	2022	Weight	2023	Weight	Delta
Canada 100.0 %	29	100.0 %	0	100.0 %	-99.44%

Managers	Title	Age	Since
Marc Lemieux CEO	Chief Executive Officer	-	31/12/14
Michael Kinley DFI	Director of Finance/CFO	73	31/12/14
Yves Marmet CTO	Chief Tech/Sci/R&D Officer	-	-
Marie-Hélène Pinard COO	Chief Operating Officer	-	-
Isabelle Bégin BRD	Director/Board Member	-	31/12/14
Annie Mercier AUD	Comptroller/Controller/Auditor	-	08/03/18
Michel Gaudette PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Marc Lemieux CEO	Chief Executive Officer	-	31/12/14
Patrick Fernet BRD	Director/Board Member	-	31/12/14
Michael Kinley DFI	Director of Finance/CFO	73	31/12/14
Isabelle Bégin BRD	Director/Board Member	-	31/12/14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	175,399,280	130,625,994 ( 74.47 %)	0	74.47 %

Name	Equities	%	Valuation
Tenshi Life Sciences Pvt. Ltd. 11.60 %	19,855,000	11.60 %	6 M $
Gestions Isamar Adstock, Inc. 7.120 %	12,190,000	7.120 %	4 M $
Marc Lemieux 6.203 %	10,621,000	6.203 %	3 M $
Isabelle Bégin 3.602 %	6,167,500	3.602 %	2 M $
Patrick Fernet 0.8600 %	1,472,500	0.8600 %	434 078 $
Michael Kinley 0.1285 %	220,000	0.1285 %	64 854 $
Yves Marmet 0.0903 %	154,645	0.0903 %	45 588 $
Marie-Hélène Pinard 0.0883 %	151,141	0.0883 %	44 555 $

KDA Group, Inc.

1351 Notre-Dame East Street Suite 300

G6G 0G5, Thetford-Mines

+877-221-4445

http://www.kdagroup.ca

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
KDA GROUP INC.	+97.50%	50.64M
MODERNA, INC.	+26.37%	48.16B
IQVIA HOLDINGS INC.	-1.01%	41.73B
LONZA GROUP AG	+42.78%	41.03B
CELLTRION, INC.	-5.31%	28.77B
ICON PUBLIC LIMITED COMPANY	+9.34%	25.59B
ALNYLAM PHARMACEUTICALS, INC.	-21.69%	18.96B
BIO-TECHNE CORPORATION	+6.23%	12.92B
MEDPACE HOLDINGS, INC.	+26.99%	12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.38%	11.77B

Other Biotechnology & Medical Research